Parabilis Medicines, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | – | – | +205.9% | |
| – | – | – | +238.9% | |
| – | – | – | +230.4% | |
| – | – | – | +240.6% | |
| – | – | – | -8.9% | |
| – | – | – | +15.9% | |
| – | – | – | -19.9% | |
| – | – | – | +23.2% | |
| – | – | – | +329.0% | |
| – | – | – | – | |
| – | +0.1% | +1.5% | +1,310.1% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.